CN102977182B - 在蛋白质纯化过程中降低样品中的一种或多种杂质水平的方法 - Google Patents

在蛋白质纯化过程中降低样品中的一种或多种杂质水平的方法 Download PDF

Info

Publication number
CN102977182B
CN102977182B CN201210398359.XA CN201210398359A CN102977182B CN 102977182 B CN102977182 B CN 102977182B CN 201210398359 A CN201210398359 A CN 201210398359A CN 102977182 B CN102977182 B CN 102977182B
Authority
CN
China
Prior art keywords
protein
activated carbon
column
eluate
flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210398359.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN102977182A (zh
Inventor
N·比安
C·吉莱斯皮
M·T·斯通
M·科兹洛夫
J·陈
M·瓦克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Millipore Corp
Original Assignee
EMD Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMD Millipore Corp filed Critical EMD Millipore Corp
Priority to CN202010257856.2A priority Critical patent/CN111423488B/zh
Priority to CN201610090272.4A priority patent/CN105669829B/zh
Publication of CN102977182A publication Critical patent/CN102977182A/zh
Application granted granted Critical
Publication of CN102977182B publication Critical patent/CN102977182B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/12—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
    • B01D15/125—Pre-filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J43/00—Amphoteric ion-exchange, i.e. using ion-exchangers having cationic and anionic groups; Use of material as amphoteric ion-exchangers; Treatment of material for improving their amphoteric ion-exchange properties
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/02—Column or bed processes
    • B01J47/04—Mixed-bed processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201210398359.XA 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质水平的方法 Active CN102977182B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010257856.2A CN111423488B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法
CN201610090272.4A CN105669829B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161575349P 2011-08-19 2011-08-19
US61/575,349 2011-08-19
US201261666240P 2012-06-29 2012-06-29
US61/666,240 2012-06-29

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN202010257856.2A Division CN111423488B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法
CN201610090272.4A Division CN105669829B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法

Publications (2)

Publication Number Publication Date
CN102977182A CN102977182A (zh) 2013-03-20
CN102977182B true CN102977182B (zh) 2016-03-02

Family

ID=47076067

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201210398359.XA Active CN102977182B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质水平的方法
CN202010257856.2A Active CN111423488B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法
CN201610090272.4A Active CN105669829B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202010257856.2A Active CN111423488B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法
CN201610090272.4A Active CN105669829B (zh) 2011-08-19 2012-08-20 在蛋白质纯化过程中降低样品中的一种或多种杂质的水平的方法

Country Status (8)

Country Link
US (3) US9096648B2 (enExample)
EP (2) EP2574618B1 (enExample)
JP (4) JP5938295B2 (enExample)
KR (1) KR101484659B1 (enExample)
CN (3) CN102977182B (enExample)
ES (2) ES2677650T3 (enExample)
TW (1) TWI574975B (enExample)
WO (1) WO2013028330A2 (enExample)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10507409B2 (en) * 2016-03-12 2019-12-17 Spf Technologies, Llc Hyper-productive chromatography system and process
US11395980B2 (en) 2010-01-25 2022-07-26 Spf Technologies Llc Chromatographic cassette
WO2013028330A2 (en) 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
JP6182210B2 (ja) * 2012-06-29 2017-08-16 イー・エム・デイー・ミリポア・コーポレイシヨン タンパク質精製プロセス中のウイルスの不活性化方法
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9650411B2 (en) * 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
ES2869232T3 (es) * 2013-02-26 2021-10-25 Emd Millipore Corp Eliminación selectiva de una proteína de una mezcla de proteínas mediante el uso de carbón activado mediante el ajuste de las condiciones de la solución
DK2968494T3 (en) * 2013-03-13 2019-03-04 Seattle Genetics Inc ACTIVATED CARBON FILTERING FOR CLEANING BENZODIAZEPINE ADCs
AU2014264697B2 (en) 2013-05-06 2019-08-22 Sanofi Continuous multistep process for purifying antibodies
EP3019262A1 (en) 2013-07-12 2016-05-18 Merck Patent GmbH Removal of fragments from a sample containing a target protein using activated carbon
US9910041B2 (en) 2013-07-12 2018-03-06 Emd Millipore Corporation Method of determining virus removal from a sample containing a target protein using activated carbon
NZ756750A (en) * 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
CN103497248B (zh) * 2013-09-22 2016-08-10 中国抗体制药有限公司 一种从细胞培养上清中分离纯化抗体的方法
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
WO2015131978A1 (en) * 2014-03-04 2015-09-11 Merck Patent Gmbh Robust antibody purification
CN114917884A (zh) * 2014-03-14 2022-08-19 思拓凡生物工艺研发有限公司 用于生物颗粒纯化的分离基质
CN107635657B (zh) * 2014-11-06 2021-02-12 默克专利股份公司 用于去除可浸出物和/或可提取物的活性炭
WO2016146594A1 (en) * 2015-03-13 2016-09-22 Novimmune Sa Methods of purifying bispecific antibodies
WO2017027861A1 (en) 2015-08-13 2017-02-16 Amgen Inc. Charged depth filtration of antigen-binding proteins
HK1259368A1 (zh) * 2015-08-20 2019-11-29 F. Hoffmann-La Roche Ag Fkpa的纯化及其用於生产重组多肽的用途
US12409440B1 (en) 2016-01-26 2025-09-09 Spf Technologies Llc Separation module
JP7037495B2 (ja) * 2016-03-17 2022-03-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ポロキサマーを精製するための方法
US20200283472A1 (en) * 2016-03-29 2020-09-10 Navya Biologicals Pvt. Ltd A process for purification of fc-fusion proteins
MX2018011435A (es) * 2016-04-01 2019-01-10 Ucb Biopharma Sprl Metodo para purificacion de proteinas.
JPWO2018092691A1 (ja) * 2016-11-18 2019-10-17 Jnc株式会社 抗体の精製方法
US20200224144A1 (en) * 2017-04-01 2020-07-16 Massachusetts Institute Of Technology Systems and methods for manufacturing biologically-produced products
WO2018211523A1 (en) * 2017-05-17 2018-11-22 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. Purification of bacterial polysaccharides
CN107236038B (zh) * 2017-06-20 2020-11-27 华兰生物工程股份有限公司 微晶纤维素提高蛋白质澄清度的方法及其产品和应用
EP3672981A4 (en) 2017-08-22 2021-09-15 Biogen MA Inc. PROCESSES FOR PURIFYING ANTIBODIES PRESENTING REDUCED AGGREGATES WITH HIGH MOLECULAR WEIGHT
WO2019147310A2 (en) 2017-08-31 2019-08-01 Massachusetts Institute Of Technology Filtration systems and methods for manufacturing biologically-produced products
US11071927B2 (en) * 2017-11-15 2021-07-27 Arup Laboratories, Inc. Separating and quantifying unbound target analytes from biological samples
CN109929038B (zh) * 2017-12-15 2020-10-09 山东博安生物技术有限公司 Vegf捕获剂融合蛋白的纯化方法
CN111818980B (zh) * 2018-03-08 2022-10-11 生物辐射实验室股份有限公司 阴离子交换-疏水混合模式色谱树脂
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
CN112566930A (zh) * 2018-06-19 2021-03-26 百时美施贵宝公司 使用色谱纯化蛋白质的方法
EP3829733B1 (en) * 2018-07-27 2024-12-18 Waters Technologies Corporation Liquid chromatography/mass spectrometry methods for the analysis of polar molecules
WO2020036869A1 (en) 2018-08-16 2020-02-20 Emd Millipore Corporation Closed bioprocessing device
CN111215027A (zh) * 2018-11-26 2020-06-02 中国科学院大连化学物理研究所 一种水热碳微球色谱介质的修饰方法
WO2020117760A1 (en) * 2018-12-03 2020-06-11 Duke University Purification method for recombinant proteins and nanoparticles
KR102120675B1 (ko) * 2018-12-05 2020-06-09 유바이오주식회사 바이러스 클리어런스 공정을 포함하는 봉독의 정제방법 및 이를 이용한 염증성 질환 예방 또는 치료용 조성물
EP3894428A4 (en) 2018-12-12 2022-09-07 Purilogics, LLC AFFINITY MEMBRANE AND METHOD FOR PREPARING IT
EP3916001A4 (en) * 2019-01-23 2022-10-19 Daiichi Sankyo Company, Limited ONE-STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES USING ACTIVATED CARBON MATERIAL
KR20210148288A (ko) * 2019-04-02 2021-12-07 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 생체내 리폴딩된 항체 단편의 클로닝 및 발현
BR112021021972A2 (pt) 2019-05-03 2021-12-21 Hoffmann La Roche Métodos de redução de uma taxa de atividade de hidrólise enzimática, de redução do nível de uma ou mais enzimas hidrolíticas e de redução da degradação de um polissorbato, composições farmacêuticas e composições de porção de anticorpo formulada
WO2021046284A1 (en) 2019-09-05 2021-03-11 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resins
KR20230152810A (ko) 2019-12-06 2023-11-03 리제너론 파아마슈티컬스, 인크. 항-vegf 단백질 조성물 및 이를 생산하는 방법
US20210178334A1 (en) * 2019-12-16 2021-06-17 Dionex Corporation Electrolytic eluent generators with stabilized operating voltages
JP2023521193A (ja) * 2020-04-13 2023-05-23 スリーエム イノベイティブ プロパティズ カンパニー フロースループロセス及び標的分子を精製するためのデバイス
JP2023525034A (ja) 2020-05-08 2023-06-14 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Ｖｅｇｆトラップおよびミニトラップならびに眼障害およびがんの治療方法
EP4237116A1 (en) * 2020-10-30 2023-09-06 Genentech, Inc. Purification platforms for obtaining pharmaceutical compositions having a reduced hydrolytic enzyme activity rate
EP4247832A1 (en) * 2020-11-20 2023-09-27 Ares Trading S.A. Buffers and methods for purifying proteins
CN116802206A (zh) 2020-12-28 2023-09-22 等离子体技术有限责任公司 用于生产规模的免疫球蛋白g分离系统和方法
KR20230125282A (ko) * 2020-12-28 2023-08-29 플라즈마 테크놀로지스, 엘엘씨 면역글로불린 G의 공정 규모 단리를 위한 시스템 및방법 (Systems and Methods for Process Scale Isolation of Immunoglobulin G)
CN112870979B (zh) * 2020-12-31 2022-12-23 内蒙古金达威药业有限公司 一种β-烟酰胺单核苷酸的分离纯化方法
CN115326937B (zh) * 2021-05-11 2024-06-18 山东省食品药品检验研究院 一种基因毒杂质捕捉用固相探针及其使用方法与应用
CN116120392B (zh) * 2023-04-18 2023-08-01 上海健士拜生物科技有限公司 聚体蛋白的纯化方法
CN118126110B (zh) * 2024-05-10 2024-08-06 江苏赛孚士生物技术有限公司 一种纯化单克隆抗体的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1577319A1 (en) * 2004-03-19 2005-09-21 Millipore Corporation Prefilter system for biological systems
WO2008025747A1 (en) * 2006-08-28 2008-03-06 Ares Trading S.A. Process for the purification of fc-fusion proteins
WO2011090720A2 (en) * 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd Purification of proteins

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31093A (en) 1861-01-08 Mode of constructing iron pavements
USRE31093E (en) 1978-05-10 1982-11-30 Westvaco Corporation Process for making activated carbon with control of metal ion concentration in phosphoric acid
JPS5918731A (ja) 1982-07-21 1984-01-31 Toray Ind Inc イオン交換繊維
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE3927112C1 (enExample) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
GB8923662D0 (en) 1989-10-20 1989-12-06 Norit Uk Ltd A method of producing granular activated carbon
JPH0778025B2 (ja) * 1990-03-20 1995-08-23 日本赤十字社 免疫グロブリンｇの製造方法
US5204310A (en) 1992-02-21 1993-04-20 Westvaco Corporation High activity, high density activated carbon
US5612558A (en) 1995-11-15 1997-03-18 Micron Technology, Inc. Hemispherical grained silicon on refractory metal nitride
US20020056686A1 (en) * 1996-06-14 2002-05-16 Agathagelos Kyrlidis Chromatography and other adsorptions using modified carbon adsorbents
DE29801192U1 (de) 1998-01-26 1998-08-20 Hans Bernstein Spezialfabrik für Schaltkontakte GmbH & Co, 32457 Porta Westfalica Radiusbetätiger für Sicherheitsschalter
DE19935160A1 (de) 1999-07-27 2001-02-15 Grove Us Llc Shady Grove Vorrichtung zur Erhöhung der Lenkfähigkeit getriebener Achsen
US6569910B1 (en) 1999-10-27 2003-05-27 Basf Aktiengesellschaft Ion exchange resins and methods of making the same
US20040028901A1 (en) 2002-02-25 2004-02-12 Rumpf Frederick H. Compositions comprising continuous networks and monoliths
CN105039464A (zh) 2002-07-01 2015-11-11 阿基昂生命科学公司,以生物技术资源部的名义经营 用于生产葡糖胺和n-乙酰氨基葡糖的方法和物质
CA2516518A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
US20080058507A1 (en) 2004-02-11 2008-03-06 Hui Liu Method For The Removal Of Aggregate Proteins From Recombinant Samples Using Ion Exchange Chromatography
SE0402558D0 (sv) * 2004-10-21 2004-10-21 Amersham Biosciences Ab A process for the purification of antibodies
WO2006073827A2 (en) * 2004-12-30 2006-07-13 Schering-Plough Ltd. Neutralizing epitope-based growth enhancing vaccine
WO2007063129A2 (en) 2005-12-02 2007-06-07 Novozymes A/S Insolation of peptides , polypeptides and proteins
WO2007067689A2 (en) 2005-12-08 2007-06-14 Waters Investments Limited Device and methods for preparation of peptides and proteins samples from solution
CA2570956C (en) * 2006-12-12 2014-04-01 Norgen Biotek Corporation Method of using silicon carbide for removal of adventitious agents
CA2687837A1 (en) * 2007-06-01 2008-12-04 F. Hoffmann-La Roche Ag Immunoglobulin purification
JP2010279461A (ja) 2009-06-03 2010-12-16 Daicen Membrane Systems Ltd 人工透析液又は人工透析用水の清浄化方法
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
SI2462158T1 (en) 2009-08-06 2018-04-30 F. Hoffmann-La Roche Ag Method to improve virus removal in protein purification
WO2011017514A1 (en) * 2009-08-07 2011-02-10 Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2013028330A2 (en) 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
JP2014527528A (ja) * 2011-08-19 2014-10-16 イー・エム・デイー・ミリポア・コーポレイシヨン 生体分子の精製方法のための小分子の使用
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
EP3019262A1 (en) * 2013-07-12 2016-05-18 Merck Patent GmbH Removal of fragments from a sample containing a target protein using activated carbon

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1577319A1 (en) * 2004-03-19 2005-09-21 Millipore Corporation Prefilter system for biological systems
WO2008025747A1 (en) * 2006-08-28 2008-03-06 Ares Trading S.A. Process for the purification of fc-fusion proteins
WO2011090720A2 (en) * 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd Purification of proteins

Also Published As

Publication number Publication date
EP2942353B1 (en) 2018-05-09
JP6743074B2 (ja) 2020-08-19
US20190218250A1 (en) 2019-07-18
JP2018091858A (ja) 2018-06-14
CN111423488B (zh) 2024-08-16
US11634457B2 (en) 2023-04-25
WO2013028330A2 (en) 2013-02-28
JP2013044748A (ja) 2013-03-04
CN105669829A (zh) 2016-06-15
US10287314B2 (en) 2019-05-14
US20130197200A1 (en) 2013-08-01
WO2013028330A3 (en) 2013-08-22
CN105669829B (zh) 2020-04-21
US9096648B2 (en) 2015-08-04
JP5938295B2 (ja) 2016-06-22
US20160016992A1 (en) 2016-01-21
EP2574618B1 (en) 2015-03-18
EP2942353A1 (en) 2015-11-11
JP2015071629A (ja) 2015-04-16
KR20130020950A (ko) 2013-03-04
KR101484659B1 (ko) 2015-01-21
CN102977182A (zh) 2013-03-20
JP6254072B2 (ja) 2017-12-27
ES2539232T3 (es) 2015-06-29
EP2574618A1 (en) 2013-04-03
TW201313735A (zh) 2013-04-01
ES2677650T3 (es) 2018-08-06
JP2016085231A (ja) 2016-05-19
JP6339120B2 (ja) 2018-06-06
TWI574975B (zh) 2017-03-21
CN111423488A (zh) 2020-07-17

Similar Documents

Publication Publication Date Title
CN102977182B (zh) 在蛋白质纯化过程中降低样品中的一种或多种杂质水平的方法
KR101415660B1 (ko) 샘플 중의 1 이상의 불순물로부터 표적 단백질을 정제하는 방법
EP2639239B1 (en) Removal of Protein Aggregates from Biopharmaceutical Preparations in a Flow-Through Mode
AU2004286938B2 (en) Removal of high molecular weight aggregates using hydroxyapatite chromatography
KR102070566B1 (ko) 크로마토그래피 방법
EP2682168A1 (en) Purification of biological molecules

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant